(Q40596029)

English

Ligand-modified vesicular stomatitis virus glycoprotein displays a temperature-sensitive intracellular trafficking and virus assembly phenotype

scientific article published on January 2004

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Ligand-modified vesicular stomatitis virus glycoprotein displays a temperature-sensitive intracellular trafficking and virus assembly phenotype (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

vesicular stomatitis

1 reference

based on heuristic

inferred from title

Erkki Ruoslahti

4

object named as

Erkki Ruoslahti

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Theodore Friedmann

5

object named as

Theodore Friedmann

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Ghiabe-Henri Guibinga

1

object named as

Ghiabe H Guibinga

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

author name string

Frederick L Hall

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Erlinda M Gordon

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Molecular Therapy

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

76-84

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.018

7 January 2021

Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.018

7 January 2021

Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.018

7 January 2021

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.018

7 January 2021

Oncoretroviral and lentiviral vector-mediated gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.018

7 January 2021

Adenovirus stripping: a versatile method to generate adenovirus vectors with new cell target specificity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.018

7 January 2021

Adaptable modification of adenoviral tropism using a bifunctional ligand protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.018

7 January 2021

Antibody-mediated targeting of an adenovirus vector modified to contain a synthetic immunoglobulin g-binding domain in the capsid

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.018

7 January 2021

Tropism-modified adenoviral and adeno-associated viral vectors for gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.018

7 January 2021

Modulation of adenovirus vector tropism via incorporation of polypeptide ligands into the fiber protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.018

7 January 2021

Systemic administration of a matrix-targeted retroviral vector is efficacious for cancer gene therapy in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.018

7 January 2021

Targeted retroviral infection of tumor cells by receptor cooperation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.018

7 January 2021

Retargeting gene delivery using surface-engineered retroviral vector particles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.018

7 January 2021

Modifying the host range properties of retroviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.018

7 January 2021

Cell surface heparan sulfate is a receptor for attachment of envelope protein-free retrovirus-like particles and VSV-G pseudotyped MLV-derived retrovirus vectors to target cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.018

7 January 2021

A simple method for displaying the hydropathic character of a protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.018

7 January 2021

Lesion-targeted injectable vectors for vascular restenosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.018

7 January 2021

Targeting retroviral vectors to vascular lesions by genetic engineering of the MoMLV gp70 envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.018

7 January 2021

Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.018

7 January 2021

VSV-G envelope glycoprotein forms complexes with plasmid DNA and MLV retrovirus-like particles in cell-free conditions and enhances DNA transfection

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.018

7 January 2021

Separable mechanisms of attachment and cell uptake during retrovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.018

7 January 2021

Proposal for a common oligosaccharide intermediate in the synthesis of membrane glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.018

7 January 2021

Oligosaccharide chains are trimmed during synthesis of the envelope glycoprotein of vesicular stomatitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.018

7 January 2021

Posttranslational folding of vesicular stomatitis virus G protein in the ER: involvement of noncovalent and covalent complexes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.018

7 January 2021

Vesicular stomatitis virus glycoprotein is sorted and concentrated during export from the endoplasmic reticulum

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.018

7 January 2021

Noninfectious virus-like particles produced by Moloney murine leukemia virus-based retrovirus packaging cells deficient in viral envelope become infectious in the presence of lipofection reagents

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.018

7 January 2021

Fluorescence microscopy in three dimensions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.018

7 January 2021

In vitro cell-free conversion of noninfectious Moloney retrovirus particles to an infectious form by the addition of the vesicular stomatitis virus surrogate envelope G protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.018

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YMTHE.2003.09.018

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40596029&oldid=1903501611"